Pfizer seeking new ruling on patent by China

Pfizer is continuing to lobby China's State Intellectual Property Office to get back its patent for Viagra. The company is asking the department to reconsider its decision overturning the Viagra patent and faces an Oct. 5 deadline for appealing the decision. A company official said Pfizer is "hopeful and cautiously optimistic" the Chinese agency will allow the decision to be appealed.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA